Bertrand D Guillonneau, Karim Fizazi. Show Affiliations »
Abstract
Entities: Species
Mesh: See more » Age FactorsDisease-Free SurvivalHumansLymphatic MetastasisMaleNeoplasm Recurrence, LocalNeoplasm StagingPatient SelectionProstate-Specific Antigen/bloodProstatectomy/adverse effectsProstatectomy/mortalityProstatic Neoplasms/immunologyProstatic Neoplasms/mortalityProstatic Neoplasms/pathologyProstatic Neoplasms/surgeryRisk AssessmentRisk FactorsSurvival RateTime FactorsTreatment Outcome
Substances: See more » Prostate-Specific Antigen
Year: 2011 PMID: 21419564 DOI: 10.1016/j.eururo.2011.02.043
Source DB: PubMed Journal: Eur Urol ISSN: 0302-2838 Impact factor: 20.096